
A study investigated the potential link between long-term use of attention-deficit/hyperactivity disorder (ADHD) treatments and cardiovascular outcomes using nationwide registers. Adult patients initiating ADHD treatment between 1998 and 2020 were categorized based on daily dosage. Results showed that compared to prior users, those receiving ≥1 defined daily dose (DDD) per day had elevated risks of stroke, heart failure, and a composite cardiovascular outcome over 10 years. These findings suggest a possible correlation between increased ADHD treatment dosage and heightened long-term cardiovascular risk in young patients, highlighting the need for further investigation into drug safety in this population.
Like
Save
Share